{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:13:17Z","timestamp":1794003197865,"version":"4.8.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","award":["#PHD\/0132\/2556"],"award-info":[{"award-number":["#PHD\/0132\/2556"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","award":["5880053"],"award-info":[{"award-number":["5880053"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.vaccine.2020.03.019","type":"journal-article","created":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T08:34:35Z","timestamp":1584174875000},"page":"3570-3581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Oral supplementation of quercetin in PRRSV-1 modified-live virus vaccinated pigs in response to HP-PRRSV-2 challenge"],"prefix":"10.1016","volume":"38","author":[{"given":"Wilawan","family":"Ruansit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasin","family":"Charerntantanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2020.03.019_b0005","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00705-015-2672-z","article-title":"Reorganization and expansion of the nidoviral family Arteriviridae","volume":"161","author":"Kuhn","year":"2016","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2020.03.019_b0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.vetmic.2017.02.020","article-title":"Pathogenesis and control of the Chinese highly pathogenic porcine reproductive and respiratory syndrome virus","volume":"209","author":"Han","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.03.019_b0015","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.virol.2015.02.012","article-title":"PRRSV structure, replication and recombination: origin of phenotype and genotype diversity","volume":"479\u2013480","author":"Kappes","year":"2015","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.vaccine.2020.03.019_b0020","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1089\/vim.2006.19.646","article-title":"Effects of porcine reproductive and respiratory syndrome virus-infected antigen-presenting cells on T cell activation and antiviral cytokine production","volume":"19","author":"Charerntantanakul","year":"2006","journal-title":"Viral Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.03.019_b0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.vetimm.2012.02.014","article-title":"Plasmids expressing interleukin-10 short hairpin RNA mediate IL-10 knockdown and enhance tumor necrosis factor alpha and interferon gamma expressions in response to porcine reproductive and respiratory syndrome virus","volume":"146","author":"Charerntantanakul","year":"2012","journal-title":"Vet Immunol Immunopathol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2020.03.019_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2015.07.003","article-title":"Innate and adaptive immunity against Porcine Reproductive and Respiratory Syndrome Virus","volume":"167","author":"Loving","year":"2015","journal-title":"Vet Immunol Immunopathol"},{"issue":"4","key":"10.1016\/j.vaccine.2020.03.019_b0035","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/vim.2009.0066","article-title":"Interleukin-10 antisense oligodeoxynucleotide suppresses IL-10 expression and effects on proinflammatory cytokine responses to porcine reproductive and respiratory syndrome virus","volume":"23","author":"Charerntantanakul","year":"2010","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2020.03.019_b0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.vetimm.2017.11.009","article-title":"Saponin Quil A up-regulates type I interferon-regulated gene and type I and II interferon expressions which are suppressed by porcine reproductive and respiratory syndrome virus","volume":"195","author":"Charerntantanakul","year":"2018","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.019_b0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1099\/jgv.0.000665","article-title":"Interleukin-1 receptor antagonist: an early immunomodulatory cytokine induced by porcine reproductive and respiratory syndrome virus","volume":"98","author":"Nedumpun","year":"2017","journal-title":"J Gen Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2020.03.019_b0050","doi-asserted-by":"crossref","first-page":"e0168314","DOI":"10.1371\/journal.pone.0168314","article-title":"Nonstructural Protein 11 of Porcine Reproductive and Respiratory Syndrome Virus Suppresses Both MAVS and RIG-I Expression as One of the Mechanisms to Antagonize Type I Interferon Production","volume":"11","author":"Sun","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.019_b0055","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.virusres.2012.03.017","article-title":"Highly pathogenic porcine reproductive and respiratory syndrome virus impairs LPS- and poly(I:C)-stimulated tumor necrosis factor-alpha release by inhibiting ERK signaling pathway","volume":"167","author":"Hou","year":"2012","journal-title":"Virus Res"},{"issue":"3","key":"10.1016\/j.vaccine.2020.03.019_b0060","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1128\/JVI.01326-09","article-title":"Porcine reproductive and respiratory syndrome virus nonstructural protein 1beta modulates host innate immune response by antagonizing IRF3 activation","volume":"84","author":"Beura","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.03.019_b0065","doi-asserted-by":"crossref","unstructured":"Wang D, Fan J, Fang L, Luo R, Ouyang H, Ouyang C, et al. The nonstructural protein 11 of porcine reproductive and respiratory syndrome virus inhibits NF-kappaB signaling by means of its deubiquitinating activity. Mol Immunol 2015 Dec;68(2 Pt A):357-66.","DOI":"10.1016\/j.molimm.2015.08.011"},{"key":"10.1016\/j.vaccine.2020.03.019_b0070","doi-asserted-by":"crossref","unstructured":"Yang L, Wang R, Ma Z, Xiao Y, Nan Y, Wang Y, et al. Porcine Reproductive and Respiratory Syndrome Virus Antagonizes JAK\/STAT3 Signaling via nsp5, Which Induces STAT3 Degradation. J Virol 2017 Feb 01;91(3).","DOI":"10.1128\/JVI.02087-16"},{"issue":"2","key":"10.1016\/j.vaccine.2020.03.019_b0075","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.virol.2010.03.039","article-title":"Modulation of type I interferon induction by porcine reproductive and respiratory syndrome virus and degradation of CREB-binding protein by non-structural protein 1 in MARC-145 and HeLa cells","volume":"402","author":"Kim","year":"2010","journal-title":"Virology"},{"issue":"15","key":"10.1016\/j.vaccine.2020.03.019_b0080","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1128\/JVI.00217-10","article-title":"The cysteine protease domain of porcine reproductive and respiratory syndrome virus nonstructural protein 2 possesses deubiquitinating and interferon antagonism functions","volume":"84","author":"Sun","year":"2010","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2020.03.019_b0085","doi-asserted-by":"crossref","first-page":"28497","DOI":"10.1038\/srep28497","article-title":"Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus Nsp4 Cleaves VISA to Impair Antiviral Responses Mediated by RIG-I-like Receptors","volume":"22","author":"Huang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.03.019_b0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.rvsc.2015.05.007","article-title":"Evolution of porcine reproductive and respiratory syndrome virus GP5 and GP3 genes under swIFN-beta immune pressure and interferon regulatory factor-3 activation suppressed by GP5","volume":"101","author":"Zhixuan","year":"2015","journal-title":"Res Vet Sci"},{"issue":"12","key":"10.1016\/j.vaccine.2020.03.019_b0095","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s00705-011-1116-7","article-title":"Porcine reproductive and respiratory syndrome virus nucleocapsid protein modulates interferon-beta production by inhibiting IRF3 activation in immortalized porcine alveolar macrophages","volume":"156","author":"Sagong","year":"2011","journal-title":"Arch Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2020.03.019_b0100","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/tbed.12190","article-title":"Comparative Analysis of Immune Responses in Pigs to High and Low Pathogenic Porcine Reproductive and Respiratory Syndrome Viruses Isolated in China","volume":"62","author":"Han","year":"2015","journal-title":"Transbound Emerg Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.019_b0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12917-016-0854-x","article-title":"Pathological and immunological characteristics of piglets infected experimentally with a HP-PRRSV TJ strain","volume":"12","author":"Li","year":"2016","journal-title":"BMC Vet Res"},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.019_b0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5501\/wjv.v1.i1.23","article-title":"Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects","volume":"1","author":"Charerntantanakul","year":"2012","journal-title":"World J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2020.03.019_b0115","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3201\/eid1812.111105","article-title":"Porcine reproductive and respiratory syndrome virus, Thailand, 2010\u20132011","volume":"18","author":"Nilubol","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.019_b0120","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3389\/fmicb.2017.01635","article-title":"Improved Vaccine against PRRSV: Current Progress and Future Perspective","volume":"8","author":"Nan","year":"2017","journal-title":"Front Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2020.03.019_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2008.12.018","article-title":"Adjuvants for porcine reproductive and respiratory syndrome virus vaccines","volume":"129","author":"Charerntantanakul","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2020.03.019_b0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.vetmic.2016.06.014","article-title":"Inactivated porcine reproductive and respiratory syndrome virus vaccine adjuvanted with Montanide Gel 01 ST elicits virus-specific cross-protective inter-genotypic response in piglets","volume":"192","author":"Tabynov","year":"2016","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.03.019_b0135","first-page":"679","article-title":"Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs","volume":"9","author":"Binjawadagi","year":"2014","journal-title":"Int J Nanomedicine"},{"issue":"41","key":"10.1016\/j.vaccine.2020.03.019_b0140","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1016\/j.vaccine.2013.07.080","article-title":"Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus","volume":"31","author":"Li","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.019_b0145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.vetimm.2018.10.005","article-title":"Co-administration of saponin quil A and PRRSV-1 modified-live virus vaccine up-regulates gene expression of type I interferon-regulated gene, type I and II interferon, and inflammatory cytokines and reduces viremia in response to PRRSV-2 challenge","volume":"205","author":"Charerntantanakul","year":"2018","journal-title":"Vet Immunol Immunopathol"},{"issue":"3","key":"10.1016\/j.vaccine.2020.03.019_b0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/nu8030167","article-title":"Quercetin, Inflammation and Immunity","volume":"8","author":"Li","year":"2016","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.vaccine.2020.03.019_b0155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0192-0561(99)00024-7","article-title":"Quercetin inhibits LPS-induced nitric oxide and tumor necrosis factor-alpha production in murine macrophages","volume":"21","author":"Manjeet","year":"1999","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.vaccine.2020.03.019_b0160","first-page":"45673","author":"Hamalainen","year":"2007","journal-title":"Mediators Inflamm 2007"},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.019_b0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0167-4889(02)00328-2","article-title":"The flavonoid, quercetin, differentially regulates Th-1 (IFNgamma) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells","volume":"1593","author":"Nair","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2020.03.019_b0170","doi-asserted-by":"crossref","unstructured":"[34] Vergauwen H, Prims S, Degroote J, Wang W, Casteleyn C, van Cruchten S, et al. In Vitro Investigation of Six Antioxidants for Pig Diets. Antioxidants (Basel) 2016 Nov 11;5(4).","DOI":"10.3390\/antiox5040041"},{"issue":"8","key":"10.1016\/j.vaccine.2020.03.019_b0175","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jn\/138.8.1417","article-title":"Tissue distribution of quercetin in pigs after long-term dietary supplementation","volume":"138","author":"Bieger","year":"2008","journal-title":"J Nutr"},{"issue":"7","key":"10.1016\/j.vaccine.2020.03.019_b0180","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s11250-018-1589-4","article-title":"Efficacy of a type 2 PRRSV modified live vaccine (PrimePac PRRS) against a Thai HP-PRRSV challenge","volume":"50","author":"Sirisereewan","year":"2018","journal-title":"Trop Anim Health Prod"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2020.03.019_b0185","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.vetimm.2005.07.026","article-title":"Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus","volume":"109","author":"Charerntantanakul","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.019_b0190","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tvjl.2011.11.019","article-title":"Effects of challenge with a virulent genotype II strain of porcine reproductive and respiratory syndrome virus on piglets vaccinated with an attenuated genotype I strain vaccine","volume":"193","author":"Roca","year":"2012","journal-title":"Vet J"},{"issue":"64","key":"10.1016\/j.vaccine.2020.03.019_b0195","article-title":"Inhibition of HSP70 reduces porcine reproductive and respiratory syndrome virus replication in vitro","volume":"14","author":"Gao","year":"2014","journal-title":"BMC Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.019_b0200","article-title":"Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV)","volume":"8","author":"Wu","year":"2015","journal-title":"Entry. Viruses"},{"issue":"2","key":"10.1016\/j.vaccine.2020.03.019_b0205","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1111\/j.1365-2893.2011.01507.x","article-title":"Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity","volume":"19","author":"Bachmetov","year":"2012","journal-title":"J Viral Hepat"},{"issue":"6","key":"10.1016\/j.vaccine.2020.03.019_b0210","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/hep.23232","article-title":"The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production","volume":"50","author":"Gonzalez","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.vaccine.2020.03.019_b0215","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jmii.2017.01.005","article-title":"Anti-apoptotic activity of Japanese encephalitis virus NS5 protein in human medulloblastoma cells treated with interferon-beta","volume":"51","author":"Weng","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2020.03.019_b0220","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s12272-017-0898-x","article-title":"The anti-HSV-1 effect of quercetin is dependent on the suppression of TLR-3 in Raw 264.7 cells","volume":"40","author":"Lee","year":"2017","journal-title":"Arch Pharm Res"},{"issue":"9","key":"10.1016\/j.vaccine.2020.03.019_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/biom9090482","article-title":"Quercetin Interrupts the Positive Feedback Loop Between STAT3 and IL-6, Promotes Autophagy, and Reduces ROS, Preventing EBV-Driven-B Cell Immortalization","volume":"9","author":"Granato","year":"2019","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.vaccine.2020.03.019_b0230","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ejps.2009.09.018","article-title":"Effects of the flavonol quercetin on the bioavailability of simvastatin in pigs","volume":"38","author":"Cermak","year":"2009","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.019_b0235","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.virol.2012.04.009","article-title":"Porcine reproductive and respiratory syndrome virus induces CD4+CD8+CD25+Foxp3+ regulatory T cells (Tregs)","volume":"430","author":"Silva-Campa","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.03.019_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2012.02.003","article-title":"Enhanced expression of TGFbeta protein in lymphoid organs and lung, but not in serum, of pigs infected with a European field isolate of porcine reproductive and respiratory syndrome virus","author":"Gomez-Laguna","year":"2012","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.03.019_b0245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vetimm.2016.02.016","article-title":"Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV","volume":"172","author":"Ko","year":"2016","journal-title":"Vet Immunol Immunopathol"},{"issue":"6","key":"10.1016\/j.vaccine.2020.03.019_b0250","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1128\/CVI.00001-15","article-title":"Comparison of Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Modified Live Vaccines against Heterologous Type 1 and Type 2 PRRSV Challenge in Growing Pigs","volume":"22","author":"Kim","year":"2015","journal-title":"Clin Vaccine Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:31:43Z","timestamp":1778679103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20303728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":50,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0264410X20303728"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.019","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral supplementation of quercetin in PRRSV-1 modified-live virus vaccinated pigs in response to HP-PRRSV-2 challenge","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}